Key result
Naloxone eliminates the larger exercise-induced beta-endorphin surge seen in asymptomatic versus symptomatic myocardial ischemia.
Why the study?
Does naloxone affect pain thresholds and plasma beta-endorphin levels during physical exercise in patients with silent versus symptomatic myocardial ischaemia?
RCT (n=17)
Double-blind
Random order
Yes
Does naloxone affect pain thresholds and plasma beta-endorphin levels during physical exercise in patients with silent versus symptomatic myocardial ischaemia?
Endogenous opioids such as beta-endorphins appear to play a role in the pathophysiology of silent myocardial ischemia by modulating pain perception during exercise.
Answers are grounded in this paper and cite their sources.
Endogenous opioids likely mediate silent ischemia; confirms beta-endorphin pathway as a mechanistic target in ischemic heart disease.
In a double-blind study, eight patients with symptomatic myocardial ischaemia and nine with asymptomatic myocardial ischaemia were compared during physical exercise under naloxone (6 mg i.v.) or placebo. Plasma beta-endorphin, cortisol and catecholamines were measured before exercise, during maximal exercise, and 10, 20 and 60 min after exercise. A tourniquet pain test (on the forearm, under control of transcutaneous PO2), and an electrical pain test (intracutaneous electrode placed in the finger with the electrical stimulus under computer control and two-interval forced-choice psychophysical technique) were performed before exercise as well as immediately after, and 60 min after exercise. Plasma beta-endorphin levels increased significantly (P less than 0.01) during exercise in symptomatic and asymptomatic patient groups; every patient showed an increase on beta-endorphins during and after exercise. However, the increase found in beta-endorphins during and after exercise was significantly larger (P less than 0.01) in asymptomatic than in symptomatic patients. After naloxone, this difference was no longer evident. Angina pectoris during exercise was reported with less latency in symptomatic patients (P less than 0.05) and occurred in two of nine asymptomatic patients following naloxone. The time course of plasma cortisol levels exhibited the same pattern as beta-endorphins with the same significant differences between symptomatic and asymptomatic groups. Electrical pain thresholds, though on average higher in asymptomatic patients (2.21 mA vs. 0.79 mA), were not affected by exercise or naloxone. Asymptomatic patients required more time to reach pain thresholds in the tourniquet pain test (P less than 0.02). After exercise, tourniquet pain thresholds were significantly lower (P less than 0.01) under naloxone compared with placebo.(ABSTRACT TRUNCATED AT 250 WORDS)
No takes yet. Share an insight, caveat, or question.
Droste et al. (1988) conducted an RCT in Myocardial ischaemia (n=17). Naloxone vs. Placebo was evaluated on Increase in plasma beta-endorphins during and after exercise (p=<0.01). Asymptomatic myocardial ischaemia patients exhibited a larger increase in plasma beta-endorphins during exercise compared to symptomatic patients, a difference that was nullified by naloxone.
Synapse has enriched 10 related papers. Consider them for comparative context: